What is THE BREATHER?

The Breather is the first drug-free evidenced based Inspiratory/Expiratory Respiratory Muscle Training (RMT) device used by COPD, CHF, Dysphagia, and Neuromuscular disease patients, as well as children and adults interested in wellness.

Cardiac & Respiratory Outcomes

17% increase in peak oxygen uptake in patients with heart failure

29% reduction in
dyspnea in patients
with heart failure

29% reduction in dyspnea in patients with heart failure

24% MIP improvement in patients with heart failure

13% MEP improvement in patients with heart failure

See Clinical Citations Below

Sleep Outcomes

Influence of 8 weeks of Inspiratory Muscle Training on Changes in Sleep Architecture in Older Adults with Sleep Apnea.

27% reduction in awakenings with 8 weeks of RMT

27% reduction in awakenings with 8 weeks of RMT

75% reduction in the sleep apnea index with 8 weeks of RMT

75% reduction in the sleep apnea index with 8 weeks of RMT

See Clinical Citations Below

COPD Outcomes

Significant clinical increase in Inspiratory Muscle Strength in just 2 weeks of RMT with COPD patients.

Significant clinical increase in Inspiratory Muscle Strength in just 2 weeks of RMT with COPD patients.

Speech & Pulmonary Outcomes

Clinical improvements seen in COPD patients using The Breather in a home health setting following the standard protocol with weekly clinical supervision.

Avg Increase After 4 wks of RMT: 110%

Avg Increase After 4 wks of RMT: 132%

Spinal Cord Injury Outcomes

117% Increase in Maximum Expiratory Strength after Acute Spinal Injury

113% Increase in Inspiratory Muscle Strength after Acute Spinal Injury

67% Increase in Peak Cough Flow after Acute Spinal Injury

Lung Age Outcomes
& Blood Vessel Elasticity

Two weeks of using the Breather® improved arterial elasticity by 10%, peripheral elasticity by 86%, and reduced lung age by 6 years in a female with unhealthy lifestyle habits.

Breather Studies Published In 2019
https://www.preprints.org/manuscript/201907.0216/v1

Pulmonary & Airway Protection Outcomes

70% clinical decrease in Aspiration of Food in Stroke Patients

168% improvement in Peak Expiratory Flow in Stroke Patients

Breather Studies Published In 2020
https://pubmed.ncbi.nlm.nih.gov/33364393

Swallow Function & Safety Outcomes

37% improvement in Swallowing Ability (MASA) in Stroke Patients

94% improvement in the range of Food Intake (FOIS) Stroke Patients with Dysphagia

Breather Studies Published In 2020
https://pubmed.ncbi.nlm.nih.gov/33364393

Phonation Outcomes

63% improvement in overall severity of Dysphonia in Stroke Patients

63% improvement in overall severity of strain (LSVT scale) in Stroke Patients

Breather Studies Published In 2021
https://pubmed.ncbi.nlm.nih.gov/33992476

Speech Inteligibility Outcomes

44% improvement in intelligibility in stroke patients with dysarthria

72% improvement in perception of intelligibility in stroke patients with dysarthria

Breather Studies Published In 2019
https://www.preprints.org/manuscript/201907.0216/v1

Ongoing or Planned Studies

IMPACT OF cRMT ON LONG COVID SYMPTOMS (COVID VIRTUAL STUDY)

Several post COVID symptoms may be associated with dysfunctional breathing
patterns or breathing dysfunctions, or with dysautonomia. Respiratory muscle
training may help alleviate the symptoms post Covid. This study is entirely remote
and app-based using PN Medical’s Breather Coach app.

MEASURED OUTCOMES

  • COVID-related symptoms
  • Return to work
  • Quality of life
In Collaboration with